Etravirine Tablet
Product Images NDC 69452-255

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Etravirine (NDC 69452-255). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image01 (Imag01)

This text provides information about Etravirine Tablets, USP, containing 100 mg of eravirng, USP, with a usual dosage specified in the package insert. It also includes storage instructions, distributor details, and a cautionary alert. The tablets are recommended for prescription use only and should not be taken with certain medicines without consulting a healthcare provider.*

FDA Label Image

Image02 (Image02)

This is a description of Evravirine Tablets, USP, containing 200 mg of the active ingredient etravirine. The text provides information on proper storage conditions, dosage instructions, and a warning about medications that should not be taken with Evravirine Tablets. It is recommended to consult a healthcare provider for further guidance on the use of this medication. Distributed by Bionpharma in Princeton, NJ.*

FDA Label Image

Chemical Structure (Structure01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.